somatostatin;
sst(5) receptor;
adenylate cyclase;
CHO-K1;
cells;
pertussis toxin;
cholera toxin;
G(alpha s) proteins;
S-35]-GTP gamma S binding and immunoprecipitation;
D O I:
10.1038/sj.bjp.0702401
中图分类号:
R9 [药学];
学科分类号:
1007 ;
摘要:
1 The coupling of the human somatostatin sst(5) receptor recombinantly expressed in Chinese hamster ovary (CHO-K1) cells to adenylate cyclase was investigated using receptor selective ligands. 2 Forskolin (10 mu M)-stimulated adenosine 3':5'-cyclic monophosphate (cyclic AMP) accumulation was inhibited by somatostatin-14 and a number of receptor-selective agonists with a rank order of agonist potency typical of the sst(5) receptor. L-362,855 and BIM-23056 behaved as full agonists. At higher somatostatin-14 concentrations there was sub-maximal inhibition resulting in a bell-shaped concentration-effect relationship. Pertussis toxin (PTx; 100 ng ml(-1), 18 h) pre-treatment abolished agonist-mediated inhibition of cyclic AMP accumulation and markedly enhanced stimulation of cyclic AMP at higher agonist concentrations. 3 The concentration of prostaglandin E-2 (PGE(2)) in the incubation media was raised 14 fold by 1 mu M somatostatin-14 but was insufficient to stimulate adenylate cyclase activity via endogenous prostanoid receptors. 4 Pre-treatment with cholera toxin (ChTx; 20 mu g ml(-1), 18 h) markedly inhibited sst(5) receptor-mediated increases in cyclic AMP formation in intact cells. Somatostatin-14-stimulated cyclic AMP accumulation was also observed in sst(5) receptor containing CHO-K1 membranes and was inhibited by the synthetic peptide G(alpha s)acetyl-354-372-amide (100 mu M) by 65.9 +/- 3.5%, implicating a G(alpha s) protein involvement in this response. 5 Activation of G(alpha s) proteins by somatostatin-14 could be demonstrated with [S-35]-guanosine 5'-[gamma-thio]triphosphate ([S-35]-GTP gamma S) binding and subsequent immunoprecipitation of S-35 labelled G(alpha s) proteins with anti-G(alpha s) serum. 6 These data show that the sst(5) receptor is very efficiently coupled in a negative manner to adenylate cyclase. However, at higher agonist concentrations the receptor can also mediate activation of adenylate cyclase by a mechanism apparently involving G(alpha s) protein activation.
机构:
Roche Biosci, Neurobiol Unit, Biol Res Ctr, Urogenital Pharmacol, Palo Alto, CA 94304 USARoche Biosci, Neurobiol Unit, Biol Res Ctr, Urogenital Pharmacol, Palo Alto, CA 94304 USA
Watson, N
Daniels, DV
论文数: 0引用数: 0
h-index: 0
机构:
Roche Biosci, Neurobiol Unit, Biol Res Ctr, Urogenital Pharmacol, Palo Alto, CA 94304 USARoche Biosci, Neurobiol Unit, Biol Res Ctr, Urogenital Pharmacol, Palo Alto, CA 94304 USA
Daniels, DV
Ford, APDW
论文数: 0引用数: 0
h-index: 0
机构:
Roche Biosci, Neurobiol Unit, Biol Res Ctr, Urogenital Pharmacol, Palo Alto, CA 94304 USARoche Biosci, Neurobiol Unit, Biol Res Ctr, Urogenital Pharmacol, Palo Alto, CA 94304 USA
Ford, APDW
Eglen, RM
论文数: 0引用数: 0
h-index: 0
机构:
Roche Biosci, Neurobiol Unit, Biol Res Ctr, Urogenital Pharmacol, Palo Alto, CA 94304 USARoche Biosci, Neurobiol Unit, Biol Res Ctr, Urogenital Pharmacol, Palo Alto, CA 94304 USA
Eglen, RM
Hegde, SS
论文数: 0引用数: 0
h-index: 0
机构:
Roche Biosci, Neurobiol Unit, Biol Res Ctr, Urogenital Pharmacol, Palo Alto, CA 94304 USARoche Biosci, Neurobiol Unit, Biol Res Ctr, Urogenital Pharmacol, Palo Alto, CA 94304 USA